Between January and June 2017, Russian manufacturers dispatch 159.8 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is 5.5% higher than that of the same period of 2016. In physical terms, the volume is 2.03 bln units, which is only 1.7% higher than that of the same period of 2016.

Between January and June 2017, Russia imported 5,600 tons of active pharmaceutical ingredients (API), worth 35.7 bln RUB (free circulation prices). In monetary terms, it is 30% higher than that of the same period of 2016. In physical terms, the dynamics is 7%.

Between January and June 2017, Russia imported 10.9 bln RUB worth of veterinary drugs (free circulation prices), 0.8 bln RUB worth of veterinary APIs, and 13.2 bln RUB worth of feed supplements and premixes. The import of veterinary APIs has the best dynamics in monetary terms (6.7%). The import of feed supplements shows the worst dynamics, with only 2.9%. The import of veterinary drugs has risen by 5.2%.

Between January and June 2017, Russia imported 238.5 bln RUB worth of ready-made drugs (free circulation prices), which is 8.1% higher in monetary terms. Due to the poor June performance, the long-term dynamics are -1%. The in-bulk import has been falling down for four months, with 42.7 bln RUB, which is 25.5% lower than that of 2016.

Between January and May 2017, Russian manufacturers produced and dispatched 135.5 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 11.1% higher than that of the same period of 2016. This is twice as low as the dynamics of 2015-2016. In physical terms, the dispatch volume is 1.73 bln units, which is 3.6% higher than that of the same period of 2016.